198 related articles for article (PubMed ID: 10193513)
21. p53 protein expression in ulcerative colitis-associated colorectal dysplasia and carcinoma.
Harpaz N; Peck AL; Yin J; Fiel I; Hontanosas M; Tong TR; Laurin JN; Abraham JM; Greenwald BD; Meltzer SJ
Hum Pathol; 1994 Oct; 25(10):1069-74. PubMed ID: 7927312
[TBL] [Abstract][Full Text] [Related]
22. MCM4 and MCM7, potential novel proliferation markers, significantly correlated with Ki-67, Bmi1, and cyclin E expression in esophageal adenocarcinoma, squamous cell carcinoma, and precancerous lesions.
Choy B; LaLonde A; Que J; Wu T; Zhou Z
Hum Pathol; 2016 Nov; 57():126-135. PubMed ID: 27476776
[TBL] [Abstract][Full Text] [Related]
23. High c-myc protein expression in benign colorectal lesions correlates with the degree of dysplasia.
Pavelic ZP; Pavelic L; Kuvelkar R; Gapany SR
Anticancer Res; 1992; 12(1):171-5. PubMed ID: 1567165
[TBL] [Abstract][Full Text] [Related]
24. Dysplasia and deoxyribonucleic acid aneuploidy in the assessment of precancerous changes in chronic ulcerative colitis. Observer variation and correlations.
Melville DM; Jass JR; Shepherd NA; Northover JM; Capellaro D; Richman PI; Lennard-Jones JE; Ritchie JK; Andersen SN
Gastroenterology; 1988 Sep; 95(3):668-75. PubMed ID: 3396815
[TBL] [Abstract][Full Text] [Related]
25. Dysplasia and carcinoma in longstanding ulcerative colitis: an endoscopic and histological surveillance programme.
Leidenius M; Kellokumpu I; Husa A; Riihelä M; Sipponen P
Gut; 1991 Dec; 32(12):1521-5. PubMed ID: 1773959
[TBL] [Abstract][Full Text] [Related]
26. Aberrant expression of minichromosome maintenance proteins 2 and 5, and Ki-67 in dysplastic squamous oesophageal epithelium and Barrett's mucosa.
Going JJ; Keith WN; Neilson L; Stoeber K; Stuart RC; Williams GH
Gut; 2002 Mar; 50(3):373-7. PubMed ID: 11839717
[TBL] [Abstract][Full Text] [Related]
27. Aberrant crypt foci as precursors of the dysplasia-carcinoma sequence in patients with ulcerative colitis.
Kukitsu T; Takayama T; Miyanishi K; Nobuoka A; Katsuki S; Sato Y; Takimoto R; Matsunaga T; Kato J; Sonoda T; Sakamaki S; Niitsu Y
Clin Cancer Res; 2008 Jan; 14(1):48-54. PubMed ID: 18172251
[TBL] [Abstract][Full Text] [Related]
28. Positive correlation of expression of L-type amino-acid transporter 1 with colorectal tumor progression and prognosis: Higher expression in sporadic colorectal tumors compared with ulcerative colitis-associated neoplasia.
Sakata T; Hana K; Mikami T; Yoshida T; Endou H; Okayasu I
Pathol Res Pract; 2020 Jun; 216(6):152972. PubMed ID: 32359697
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical assessment of Ki67 and p53 expression assists the diagnosis and grading of ulcerative colitis-related dysplasia.
Wong NA; Mayer NJ; MacKell S; Gilmour HM; Harrison DJ
Histopathology; 2000 Aug; 37(2):108-14. PubMed ID: 10931232
[TBL] [Abstract][Full Text] [Related]
30. Evidence for immunosurveillance in intestinal premalignant lesions.
Karlsson M; Lindberg K; Karlén P; Ost A; Thörn M; Winqvist O; Eberhardson M
Scand J Immunol; 2010 May; 71(5):362-8. PubMed ID: 20500687
[TBL] [Abstract][Full Text] [Related]
31. MCM2 expression in serrated polyps demonstrates aberrant cellular proliferation.
Fortuna D; Boman B; O'Neill R; Palazzo J
Hum Pathol; 2017 May; 63():177-183. PubMed ID: 28302537
[TBL] [Abstract][Full Text] [Related]
32. Dysplasia in ulcerative colitis as a predictor of unsuspected synchronous colorectal cancer.
Murphy J; Kalkbrenner KA; Pemberton JH; Landmann RG; Heppell JP; Young-Fadok TM; Etzioni DA
Dis Colon Rectum; 2014 Aug; 57(8):993-8. PubMed ID: 25003294
[TBL] [Abstract][Full Text] [Related]
33. [Dysplasia in ulcerative colitis].
Werner M; Mueller E
Verh Dtsch Ges Pathol; 1999; 83():122-9. PubMed ID: 10714202
[TBL] [Abstract][Full Text] [Related]
34. Ulcerative colitis with overexpression of p53 preceding overt histological abnormalities of the epithelium.
Matsuda K; Watanabe H; Ajioka Y; Kobayashi M; Saito H; Sasaki M; Yasuda K; Kuwabara A; Nishikura K; Muto T
J Gastroenterol; 1996 Dec; 31(6):860-7. PubMed ID: 9027653
[TBL] [Abstract][Full Text] [Related]
35. [Expression of CD10 in tumor-associated fibroblast of cancerized or recurrent colorectal adenomas].
Zheng J; Zhu Y; Li C; Li Y; Nie Q; Zhu Z; Deng H
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 May; 45(4):335-341. PubMed ID: 27868405
[TBL] [Abstract][Full Text] [Related]
36. [The pathogenesis of ulcerative colitis-associated colorectal cancer].
Sipos J
Magy Onkol; 2004; 48(1):35-43. PubMed ID: 15105894
[TBL] [Abstract][Full Text] [Related]
37. Altered expression of CK7 and CK20 in preneoplastic and neoplastic lesions in ulcerative colitis.
Stenling R; Lindberg J; Rutegård J; Palmqvist R
APMIS; 2007 Nov; 115(11):1219-26. PubMed ID: 18092953
[TBL] [Abstract][Full Text] [Related]
38. Differential diagnosis of adenomas and dysplastic lesions in patients with ulcerative colitis.
Schneider A; Stolte M
Z Gastroenterol; 1993 Nov; 31(11):653-6. PubMed ID: 8291276
[TBL] [Abstract][Full Text] [Related]
39. [Morphological and immunohistochemical quantitative analysis of dysplasia in ulcerative colitis. 1. Histological mapping specimen and morphological quantitative analysis].
Oikawa T
Nihon Shokakibyo Gakkai Zasshi; 1992 Feb; 89(2):477-85. PubMed ID: 1569702
[TBL] [Abstract][Full Text] [Related]
40. 'Serrated' adenoma of the colorectum, with reference to its gastric differentiation and its malignant potential.
Yao T; Kouzuki T; Kajiwara M; Matsui N; Oya M; Tsuneyoshi M
J Pathol; 1999 Apr; 187(5):511-7. PubMed ID: 10398114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
